Dilaudid is the brand name for hydromorphone, a powerful opioid analgesic used for managing moderate to severe pain [1]. It is available in various formulations, including oral tablets, oral solution, and injectable solutions [1].
What is Dilaudid used for?
Dilaudid is prescribed for the short-term and long-term management of chronic and acute pain [1]. Its potency makes it effective for pain levels that do not respond to less potent analgesics.
How does Dilaudid work?
Hydromorphone, the active ingredient in Dilaudid, is a Schedule II controlled substance [1]. It acts on the central nervous system by binding to opioid receptors, which alters the body's perception of pain [1].
When does Dilaudid patent exclusivity expire?
DrugPatentWatch.com tracks patent and exclusivity information for medications. Specific patent expiry dates for Dilaudid would need to be consulted on their platform for the most accurate and up-to-date details, as patents can be complex and involve multiple filings.
Who manufactures Dilaudid?
AbbVie manufactures Dilaudid [1].
What are the risks associated with Dilaudid?
As an opioid, Dilaudid carries significant risks, including the potential for addiction, abuse, and overdose [1]. Respiratory depression is a primary concern, which can be fatal [1]. Other side effects can include dizziness, drowsiness, nausea, and constipation [1]. Patients should use Dilaudid only as prescribed and under the supervision of a healthcare professional.